Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 17Terminated 3Recruiting 3Active not recruiting 3Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 283Lymphoid 14Other solid neoplasm 11Thoracic 6Tumor-Agnostic 4Head & Neck 2Gynecologic 2Breast 2Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Other 1Genitourinary 1Dermatologic 1CNS 1

Conditions

Carcinoma, Renal Cell 1

Interventions

Docetaxel 33Radiosurgery 22Radiotherapy 21Sunitinib 20pembrolizumab 17Gemcitabine 16Cisplatin 16Androgen Antagonists 15enzalutamide 13Nivolumab 13Goserelin 12Blood Specimen Collection 12aldesleukin 11Surveys and Questionnaires 11Prednisone 11Leuprolide 11Cyclophosphamide 11Abiraterone Acetate 11Bevacizumab 10bicalutamide 9Multiparametric Magnetic Resonance Imaging 9Carboplatin 9acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 8Gonadotropin-Releasing Hormone 8Filgrastim 8Epirubicin 8Chemotherapy, Adjuvant 8Brachytherapy 8toripalimab 7tislelizumab 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Oxaliplatin × Genitourinary × Clear all
NCT04049344 2019-08-08

Decitabine Combined With Oxaliplatin in Patients With Advanced Renal Cell Carcinoma

Zhejiang Cancer Hospital

Phase 2 Unknown
25 enrolled
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡